Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FRMPD3 antisense RNA 1 (FRMPD3-AS1) is a long non-coding RNA (lncRNA) whose sequence is antisense to the FRMPD3 gene. To the best of current knowledge, it does not encode a protein. It is transcribed from the antisense strand of the FRMPD3 gene locus. Its exact function, biological role, and disease relevance remain poorly characterized. Unlike protein-coding genes or well-established therapeutic targets, FRMPD3-AS1 is not currently classified as a receptor, enzyme, or direct drug target. Research into its regulatory or structural roles is ongoing, but no direct clinical associations, functional mechanisms, interacting drugs, disease associations, or use as a biomarker have yet been demonstrated in public databases for FRMPD3-AS1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FRMPD3 antisense RNA 1 (FRMPD3-AS1).